Hyperfine Rolls Out Model 2 Swoop Brain MRI in Europe

Hyperfine revealed that it has launched its next-generation Swoop portable brain MRI system in Europe. The next-gen Swoop system boasts the latest advancement in the company’s Optive AI software.

Now that it’s claimed CE mark and UKCA approval, the system, also known as Model 2, can now be sold in an initial wave of European markets. Hyperfine also said the Model 2 Swoop is now included in the UniHA procurement listing, which allows broader adoption for hospitals in the French public healthcare system.

The European commercial launch adds to the company’s recent corporate milestone of inclusion into the Russell 2000 Index.

Comments from Hyperfine and clinicians

Eric Willis, president of International, Hyperfine: “We are proud to bring Hyperfine’s most advanced portable MRI technology to clinicians across Europe and the UK, delivering on an important milestone for our commercialization strategy in 2026. The next-generation system delivers significant improvements in image quality, workflow efficiency, and clinical capability. We have already seen these advancements accelerate use and adoption of the Swoop system throughout the United States. We look forward to working closely with our distribution partners to expand access to AI-powered portable MRI across Europe, providing critical neuroimaging that helps clinicians make more timely and more informed patient care decisions. By the end of the year, we plan to make the Model 2 Swoop system available through our distribution partners across all European markets where Hyperfine is represented.”

Professor Steve Williams, professor of neuroimaging, King’s College London; head of the department of neuroimaging at the Institute of Psychiatry, Psychology & Neuroscience: “I’ve been involved with Hyperfine since the earliest days of portable MRI, and the relentless progress has been remarkable. With the next-generation Swoop system, the improvement in image quality is transformative. Having spent my career exploring advanced brain imaging, I am impressed that low-field MRI can provide this level of diagnostic-quality images. For years, limited access to neuroimaging has delayed diagnosis and treatment for countless patients around the world. The Swoop system is uniquely positioned to address that gap, making MRI accessible when and where it is needed, even in remote locations, to support decision-making in a wider range of care settings across the lifespan.”